2017 American Transplant Congress
A Novel Technique to Increase Donor Utilization: Our Experience Using High-Dose Tissue Plasminogen Activator Flush in Donation-After-Cardiac-Death Donors for Liver Transplantation.
Surgery, Montefiore Medical Center, Bronx, NY
The utilization of donation-after-cardiac-death (DCD) livers remains generally low. Strategies to address the perceived liabilities associated with DCD organs could influence their utilization in a…2017 American Transplant Congress
Is It Safe to Use Older Donor Liver Grafts for Older Recipients?
Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI
Aim: The safety of liver transplantation (LT) using older donor grafts into older recipients remains to be elucidated. The aim of this study was to…2017 American Transplant Congress
Rapid Deterioration of Pre-Transplant Kidney Function Requiring Dialysis Is a Prognostic Factor in Liver Transplant Alone.
Aim: Etiologies of acute kidney injury before liver transplant extend beyond hepatorenal syndrome (ie infection, gastrointestinal bleeding) and therefore, may not be resolved by liver…2017 American Transplant Congress
Treating Refractory Liver Allograft Rejection with Photopheresis.
DSAs with persistent high titer alloantibodies are associated with refractory antibody mediated rejection (AMR) and liver injury.METHODS: We present 4 liver transplant (LT) patients refractory…2016 American Transplant Congress
Which Is the Predictable Values of Post-Transplant Hepatocellular Carcinoma Recurrence in Patients Received Down Staging Therapy or Bridging Therapy?
Introduction: Liver transplantation (LT) is one of the best treatment for small hepatocellular carcinoma (HCC) in patients with liver cirrhosis. However, many patients do not…2016 American Transplant Congress
Increasing Volume and Improved Survival in Solid Organ Transplantation for Amyloidosis – An Analysis of the UNOS Database.
Background: Amyloidosis is a rare disease that results from accumulation of inappropriately folded proteins causing organ failure and poor prognosis. In the last decade several…2016 American Transplant Congress
Impact of Left Ventricular Diastolic Dysfunction on Patients Being Evaluated for Liver Transplantation.
IntroductionDiastolic dysfunction (DD) is the cardinal finding in cirrhotic cardiomyopathy, a condition in patients with liver disease that is associated with an increased risk of…2016 American Transplant Congress
Thrombolytic Protocol in Organ Procurement from Donation After Circulatory Death Donors Reduces Ischemic Cholangiopathy in Liver Transplantation.
Miami Transplant Institute, Miami.
Liver transplantation (LT) with donation after circulatory death (DCD) donors has been associated with a higher rate (up to 50%) of complications of ischemic cholangiopathy…2016 American Transplant Congress
The Correlation of Hepatic and Systemic Hemodynamics During Liver Transplantation: Quantification of Hepatic Resistance as an Actual Value.
Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
PurposeThe correlation between portal vein pressure (PVP) and flow (PVF) has not been established, and there is still lack of consensus about the optimal hemodynamics…2016 American Transplant Congress
Clinical Predictors of Progression and Clearance of Low Level CMV Viremia in Solid Organ Transplant Recipients.
Multi-Organ Transplant Program, University Health Network, Toronto, ON, Canada.
Background: Low level CMV viremia is common, and may either progress to higher viral loads that require therapy, or may spontaneously resolve. The clinical predictors…
- « Previous Page
- 1
- …
- 141
- 142
- 143
- 144
- 145
- …
- 180
- Next Page »